lipid
raft
lr
play
crucial
role
complex
physiolog
process
modul
innat
acquir
immun
respons
pathogen
transmembran
ctype
lectin
human
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
mous
homolog
distribut
lr
express
splenic
margin
zone
mz
macrophag
complex
could
mediat
immunoglobulin
ig
independ
classic
complement
pathway
streptococcu
pneumonia
precis
role
lr
complement
pathway
unknown
show
lr
indispens
acceler
dcsignor
classic
complement
pathway
pneumonia
thu
facilit
rapid
clearanc
pathogen
trimolecular
complex
exclus
enrich
lr
splenic
mz
macrophag
local
essenti
activ
catabol
enhanc
pneumococc
clearanc
abolish
mice
howev
dcsign
replac
splenic
mz
macrophag
lr
mice
revers
defect
disrupt
lr
dramat
reduc
pneumococc
uptak
decomposit
addit
dcsign
obvious
distribut
splenic
lr
cadav
therefor
lr
splenic
dcsign
macrophag
could
provid
spatial
confin
optim
bidirect
platform
usual
intracellular
event
exampl
recognit
phagocytosi
pathogen
also
unusu
extracellular
event
complement
system
find
improv
understand
orchestr
role
spleen
unravel
new
innat
immun
system
initi
splenic
mz
lr
yield
answer
sever
longstand
problem
includ
need
understand
profound
role
lr
innat
immun
need
identifi
small
portion
splenic
macrophag
splenic
macrophag
effect
resist
pneumonia
need
understand
lr
promot
protect
function
dcsign
pneumonia
human
spleen
lipid
raft
lr
small
nm
highli
dynam
detergentresist
membran
fraction
enrich
cholesterol
glycosphingolipid
content
plasma
membran
eukaryot
cell
although
lr
compris
small
percentag
cell
surfac
area
size
increas
coalesc
raft
unit
provid
spatiotempor
platform
mani
molecular
entiti
lr
play
crucial
role
complex
physiolog
process
phagocytosi
receptorreceptor
associ
receptorpathogen
associ
signal
transduct
mani
patholog
situat
modul
innat
acquir
immun
respons
complement
system
import
sever
innat
adapt
resist
mechan
consist
highli
regul
cascad
serum
complement
protein
trigger
recognit
microb
system
activ
classic
solubl
mannosebind
lectin
mbl
altern
pathway
pivot
step
complement
pathway
assembl
convertas
digest
form
microbi
bind
fragment
fragment
serv
ligand
complement
receptor
reciproc
bind
promot
uptak
kill
microb
phagocyt
thu
complement
system
provid
major
extracellular
defens
mechan
infecti
organ
variou
immun
receptor
lr
fc
receptor
cytokin
receptor
b
cell
receptor
cell
receptor
increas
bind
capac
cluster
facilit
signal
favor
clearanc
intracellular
pathogen
innat
pattern
recognit
receptor
tolllik
receptor
transmembran
ctype
lectin
transloc
lr
upon
stimul
specif
agonist
thu
demonstr
import
membran
partit
innat
immun
recognit
variou
pathogen
addit
variou
complement
receptor
globular
receptor
complement
regulatori
protein
distribut
lr
immun
cell
transmembran
ctype
lectin
human
dendrit
cellspecif
intercellular
adhes
nonintegrin
dcsign
murin
homolog
exhibit
sever
common
specif
act
princip
receptor
pneumococc
capsular
polysaccharid
pneumonia
cp
human
immunodefici
bind
complement
show
distribut
lr
vitro
addit
initi
immunoglobulin
ig
independ
classic
complement
pathway
interact
pneumonia
particularli
cellular
surfac
splenic
margin
zone
mz
macrophag
facilit
rapid
clearanc
similarli
complex
may
provid
initi
site
classic
complement
pathway
pathogen
condit
although
disrupt
lr
significantli
reduc
dcsignand
pneumococc
phagocytosi
specif
mechan
still
unknown
accordingli
studi
role
lr
examin
ctype
lectinmedi
phagocytosi
order
elucid
role
dcsign
human
spleen
lr
splenic
mz
dcsign
macrophag
may
import
dcsignmedi
uptak
decomposit
pneumonia
dcsign
transfect
immunostain
dcsign
raft
protein
gangliosid
fluorescein
isothiocyan
fitc
cholera
toxin
b
ctb
subunit
larg
aggreg
dcsign
strongli
distribut
ctbenrich
vertex
region
cell
fig
moreov
dcsign
monom
dimer
obvious
enrich
lr
fraction
fraction
compar
nonlr
fraction
fig
isol
detergentresist
raft
fraction
confirm
immunoblot
repres
marker
planar
lr
caveola
respect
experi
perform
deplet
dcsign
transgen
mice
dcsign
bmt
tko
fig
supplementari
fig
b
human
cadav
supplementari
fig
dcsign
obvious
express
lr
splenic
mz
dcsign
cell
fig
supplementari
fig
disrupt
lr
cholesterolextract
agent
reduc
dcsign
express
cellular
surfac
alter
surfac
distribut
pattern
fig
moreov
dcsign
transfect
incub
carboxyfluorescein
succinimidyl
ester
cfse
label
pneumonia
pneumococc
uptak
decomposit
obviou
cytoplasm
show
disintegr
particl
pneumococc
capsular
polysaccharid
pneumonia
serotyp
around
phagocytos
bacterium
fig
supplementari
fig
similar
result
observ
pretreat
actinomycind
cycloheximid
affect
plasma
membran
structur
fig
howev
pneumococc
uptak
decomposit
dramat
reduc
disrupt
lr
use
fig
supplementari
fig
inhibit
lrdepend
endocytosi
use
dynamin
inhibitori
peptid
dip
transfect
dominantneg
dynamin
fig
h
respect
permit
microbi
bind
cellular
surfac
dcsign
transfect
bacteri
decomposit
ratio
quantit
calcul
fig
lr
splenic
mz
macrophag
may
import
uptak
decomposit
pneumonia
larg
aggreg
observ
ctbenrich
vertex
region
transfect
strong
distribut
monom
dimer
obviou
lr
fraction
fig
particular
multim
preform
lr
inset
fig
whole
fraction
spleen
lymph
node
wildtyp
wt
mice
evid
lr
tissu
wt
mice
higher
concentr
multim
lr
nonlr
fig
ko
mice
fig
supplementari
fig
fig
distribut
dcsign
splenic
lipid
raft
role
uptak
decomposit
pneumonia
left
dcekdcsign
transfect
immunostain
dcsign
red
cholera
toxin
b
green
dapi
blue
arrowhead
yellow
indic
coloc
dcsign
cholera
toxin
b
right
sucros
gradient
ultracentrifug
wholecel
lysat
dcekdcsign
transfect
fraction
immunoblot
dcsign
b
dcsign
bmt
wt
mice
intraven
inject
hamster
igg
monoclon
antibodi
h
splenic
cryosect
immunostain
green
dcsign
red
blue
c
right
spleen
dcsign
bmt
tko
mice
use
immunoblot
perform
right
cadav
spleen
use
repres
result
present
e
left
dcekdcsign
transfect
treat
mm
h
immunostain
dcsign
without
permeabil
assess
fac
right
left
cell
immunostain
cholera
toxin
b
green
dcsign
red
follow
microscop
analysi
fh
left
dcekdcsign
transfect
pretreat
f
actinomycind
ad
h
cycloheximid
ch
h
g
myristoyl
dynamin
inhibitori
peptid
h
wash
h
transfect
empti
vector
dominantneg
dynamin
sampl
incub
mitomycin
ctreat
pneumonia
type
h
follow
immunostain
f
g
dcsign
green
red
h
dynamin
green
red
right
averag
percentag
pneumococc
decomposit
total
pneumococc
bind
dcsign
transfect
calcul
five
area
sampl
five
independ
experi
data
shown
mean
sd
ns
signific
p
p
p
scale
bar
f
g
h
b
e
disrupt
lr
reduc
express
transfect
cellular
surfac
alter
surfac
distribut
pattern
fig
howev
treatment
transfect
reduc
uptak
dextran
repres
ligand
fig
similarli
transfect
incub
pneumonia
type
strong
bind
affin
uptak
decomposit
organ
evid
control
condit
fig
supplementari
fig
presenc
actinomycind
cycloheximid
fig
howev
treatment
transfect
inhibit
uptak
decomposit
pneumonia
permit
microbi
bind
cellular
surfac
right
spleen
wildtyp
mice
use
immunoblot
left
transfect
treat
mm
h
immunostain
without
permeabil
assess
fac
right
left
cell
immunostain
cholera
toxin
b
green
red
follow
microscop
analysi
e
cell
incub
fitcdextran
min
h
uptak
assess
fac
green
pink
line
uptak
without
respect
fh
left
transfect
pretreat
f
actinomycind
ad
h
cycloheximid
cd
h
g
myristoyl
dynamin
inhibitori
peptid
h
wash
h
transfect
dominantneg
dynamin
incub
mitomycin
ctreat
pneumonia
type
h
follow
immunostain
f
g
green
red
h
dynamin
green
red
right
averag
percentag
pneumococc
decomposit
total
pneumococc
bind
transfect
calcul
five
area
sampl
five
independ
experi
data
shown
mean
sd
ns
signific
p
p
p
scale
bar
f
g
h
fig
moreov
inhibit
lrdepend
endocytosi
use
dip
dramat
reduc
uptak
decomposit
organ
fig
h
bacteri
decomposit
ratio
quantit
calcul
fig
lr
splenic
mz
macrophag
may
provid
optim
locat
innat
recruit
pneumonia
vivo
transfect
incub
pneumonia
presenc
abund
aggreg
observ
cell
surfac
fig
b
cell
fraction
lr
fraction
immunoblot
monom
multim
obvious
increas
lr
fig
macrophag
rapidli
recogn
pneumonia
splenic
mz
within
h
fig
distribut
splenic
lr
examin
h
intraven
inject
pneumonia
complex
obvious
increas
splenic
lr
follow
pneumonia
stimul
fig
confirm
separ
experi
supplementari
fig
case
similar
experi
use
intraven
inject
unencapsul
mutant
pneumonia
serotyp
staphylococcu
aureu
anoth
gramposit
coccal
bacterium
bind
show
increas
complex
splenic
lr
fig
g
confirm
depend
recruit
complex
pneumonia
next
examin
whether
marco
scaveng
receptor
express
partial
mz
macrophag
cell
adhes
molecul
express
mz
metallophil
recruit
splenic
lr
follow
pneumonia
exposur
neither
target
recruit
splenic
lr
follow
exposur
pneumonia
fig
distribut
lr
splenic
mz
macrophag
increas
follow
pneumonia
exposur
manner
vivo
express
level
wholecel
lysat
spleen
liver
lung
control
mice
similar
tissu
supplementari
fig
howev
higher
level
found
splenic
lr
hepat
pulmonari
lr
nonlr
tissu
fig
tradit
mediat
differ
complement
pathway
igm
mblc
factor
b
bare
present
lr
tissu
fig
variabl
nonlr
supplementari
fig
follow
intraven
inject
phosphatebuff
salin
pb
pneumonia
simultan
increas
obviou
splenic
lr
wherea
chang
found
hepat
pulmonari
lr
nonlr
fig
addit
differ
igm
mblc
factor
b
level
found
fraction
fig
supplementari
fig
mice
level
wholecel
lysat
tissu
control
mice
supplementari
fig
b
howev
complement
increas
follow
pneumonia
exposur
fig
moreov
increas
complet
abolish
splenic
lr
tko
mice
expos
pneumonia
supplementari
fig
determin
whether
specif
recognit
requir
upregul
splenic
lr
splenic
fraction
immunoblot
complement
upregul
splenic
fraction
follow
exposur
aureu
fig
g
lr
splenic
mz
macrophag
may
provid
optim
locat
domin
activ
respons
pneumonia
manner
vivo
examin
level
wholecel
lysat
spleen
liver
lung
wt
mice
lowest
express
observ
spleen
supplementari
fig
howev
immunoblot
fraction
show
constitut
distribut
highest
splenic
lr
among
lr
tissu
fig
furthermor
follow
intraven
inject
pb
pneumonia
initi
activ
domin
splenic
lr
expos
pneumonia
dramat
decreas
rel
minor
decreas
observ
splenic
nonlr
fig
result
spleen
fraction
confirm
separ
experi
supplementari
c
sera
splenic
fraction
tko
mice
defici
affect
level
sera
supplementari
distribut
splenic
lr
without
pneumococc
challeng
fig
top
supplementari
fig
g
top
abolish
activ
pneumococc
challeng
fig
bottom
supplementari
fig
bottom
moreov
essenti
activ
splenic
lr
activ
significantli
decreas
abolish
splenic
fraction
wt
mice
follow
aureu
challeng
yield
abund
intact
weak
increas
kda
fig
e
mice
defici
splenic
lr
effect
constitut
distribut
splenic
lr
increas
pneumonia
fig
wt
cell
transfect
incub
mous
serum
fixat
observ
transfect
significantli
enhanc
transfect
accumul
multimer
splenic
lipid
raft
follow
exposur
pneumonia
vivo
transfect
incub
mitomycin
ctreat
pneumonia
type
min
immunostain
without
permeabil
b
cell
pretreat
mm
h
incub
c
cell
lysat
fraction
sucros
gradient
ultracentrifug
fraction
lr
immunoblot
multim
shown
box
total
cfselabel
green
inject
intraven
wildtyp
mice
min
splenic
section
immunostain
blue
bind
uptak
organ
splenic
mz
shown
box
e
c
spleen
use
intraven
inject
live
pneumonia
hr
wildtyp
mice
f
g
e
mice
inject
intraven
pb
cell
unencapsul
mutant
serotyp
pneumonia
staphylococcu
aureu
h
respect
h
e
fraction
immunoblot
marco
scale
bar
b
presenc
pneumonia
fig
furthermor
fluoresc
microscopi
reveal
coloc
transfect
fig
supplementari
fig
indic
activ
specif
gener
locat
cell
classic
complement
pathway
initi
enrich
enhanc
opson
uptak
decomposit
pneumonia
addit
significantli
enhanc
fixat
pneumococc
surfac
fig
sequenti
increas
concentr
also
acceler
opson
respons
fig
predomin
distribut
complement
splenic
lipid
raft
upregul
pneumonia
challeng
manner
vivo
spleen
liver
lung
control
mice
fraction
sucros
gradient
ultracentrifug
fraction
immunoblot
b
fraction
immunoblot
igm
mblc
factor
b
c
wildtyp
mice
inject
intraven
live
pneumonia
h
c
fraction
immunoblot
igm
mblc
factor
b
e
c
mice
use
splenic
fraction
analyz
f
g
c
mice
inject
intraven
unencapsul
mutant
serotyp
pneumonia
staphylococcu
aureu
h
data
repres
five
independ
experi
fig
domin
activ
splenic
lipid
raft
manner
follow
pneumonia
challeng
vivo
spleen
liver
lung
control
mice
fraction
sucros
gradient
ultracentrifug
fraction
immunoblot
b
wildtyp
mice
inject
intraven
pb
live
pneumonia
h
c
b
mice
use
splenic
fraction
analyz
e
c
mice
inject
intraven
unencapsul
mutant
serotyp
pneumonia
staphylococcu
aureu
h
f
c
cvftreat
mice
use
splenic
fraction
immunoblot
g
dcekwt
incub
mitomycin
ctreat
pneumonia
type
h
without
nm
tc
buffer
min
cell
immunostain
respect
isotyp
control
igg
assess
fac
h
g
bind
red
green
assess
fluoresc
microscopi
fix
transfect
paraformaldehyd
arrowhead
indic
coloc
repres
cell
shown
box
data
repres
five
independ
experi
scale
bar
h
pneumonia
led
format
membran
attack
complex
pneumonia
fig
amount
use
fixat
amount
fix
pneumonia
condit
howev
activ
domin
addit
demonstr
degrad
increas
fixat
small
kda
fig
addit
normal
human
serum
nh
sourc
pneumococc
bind
increas
transfect
fig
moreov
pneumococc
uptak
sequenti
decomposit
observ
transfect
normal
mous
serum
nm
without
serum
sera
fig
supplementari
fig
intraven
inject
pneumonia
wt
mice
pneumococc
uptak
cytoplasm
decomposit
obviou
splenic
mz
macrophag
control
mice
fig
supplementari
fig
complet
abolish
splenic
mz
mice
red
pulp
mice
fig
signal
specif
splenic
mz
macrophag
control
mice
fig
confirm
immunostain
respect
isotyp
control
immunoglobulin
supplementari
fig
dcsign
may
mediat
classic
complement
pathway
lr
splenic
mz
dcsign
macrophag
follow
pneumonia
challeng
via
interact
dcsign
transfect
treat
pneumonia
dcsign
aggreg
dramat
increas
cell
surfac
fig
addit
lr
fraction
cell
immunoblot
dcsign
monom
dimer
dcsign
obvious
increas
lr
follow
pneumonia
challeng
fig
moreov
splenic
mz
dcsign
macrophag
dcsign
bmt
tko
mice
recov
rapid
recognit
pneumonia
splenic
mz
even
min
h
intraven
inject
organ
fig
spleen
h
dcsign
monom
multim
obvious
upregul
splenic
lr
follow
pneumonia
challeng
fig
dcsign
bound
well
purifi
human
human
nh
fig
addit
dcsign
bind
mous
nm
confirm
immunoblot
immunostain
fig
supplementari
fig
examin
whether
dcsign
bound
directli
similar
supplementari
fig
dcsign
transfect
show
clear
fixat
fig
addit
dcsigntransfect
cell
also
induc
fixat
nh
confirm
bind
dcsign
fig
fixat
significantli
increas
follow
pneumonia
challeng
fig
splenic
fraction
dcsign
bmt
tko
mice
upregul
obviou
follow
pneumonia
challeng
fig
moreov
intraven
inject
pneumonia
dcsign
bmt
tko
mice
system
activ
reappear
tko
mice
control
mice
demonstr
gradual
decreas
larger
rapid
increas
sequenti
decreas
small
fig
fixat
also
complet
recov
around
splenic
mz
dcsign
macrophag
dcsign
bmt
tko
mice
tko
mice
control
mice
fig
supplementari
fig
occur
rapidli
within
min
challeng
pneumonia
disappear
h
supplementari
fig
immunostain
isotyp
control
igg
antibodi
yield
signal
supplementari
fig
moreov
immunoblot
cadav
spleen
reveal
express
human
splenic
lr
predomin
express
rather
fig
supplementari
fig
although
dcsign
profession
recogn
remov
pneumonia
disrupt
lr
lectin
transfect
result
seriou
impair
uptak
sequenti
decomposit
organ
disrupt
lr
alter
express
level
lectin
respect
transfect
would
lead
normal
bind
organ
cell
surfac
structur
lr
may
import
function
lectin
remov
pneumonia
previous
thought
see
figur
previou
page
fig
activ
opson
pneumonia
enhanc
uptak
decomposit
bacteria
cell
vitro
vivo
live
pneumonia
type
incub
nh
min
presenc
bovin
serum
albumin
transferrin
tfe
purifi
immunostain
analyz
fac
b
tfe
use
organ
immunostain
membran
attack
complex
mac
c
organ
immunoblot
total
mitomycin
ctreat
pneumonia
incub
cho
transfect
presenc
nh
bind
organ
cell
assess
fac
e
dceksign
transfect
incub
h
without
mous
sera
nm
mous
sera
cell
immunostain
green
red
follow
microscop
analysi
repres
cell
shown
box
f
green
inject
intraven
control
mice
h
spleen
section
immunostain
blue
red
repres
area
splenic
mz
highlight
box
middl
row
organ
captur
red
pulp
arrowhead
highlight
bottom
row
scale
bar
e
f
fig
see
legend
next
page
specul
strongli
support
follow
result
first
multim
dcsign
preform
lr
respect
transfect
even
multim
preform
splenic
lr
addit
dcsign
multim
increas
lr
follow
pneumonia
challeng
vitro
vivo
nonlr
therefor
lr
could
provid
spatial
confin
optim
platform
dcsign
facilit
cluster
increas
affin
specif
pathogen
enhanc
clearanc
thu
affect
innat
protect
function
raft
locat
target
antigen
favor
classic
complement
activ
concentr
antigenantibodi
complex
compar
small
area
thu
provid
ideal
densiti
juxtapos
fc
region
engag
similarli
exclus
distribut
splenic
lr
among
fraction
examin
mous
tissu
show
signific
depend
exist
exclus
express
splenic
mz
macrophag
bound
directli
addit
potenti
interact
therefor
exclus
distribut
splenic
lr
expect
protein
may
subdivid
splenic
mz
lr
heterogen
lr
variou
splenic
cell
find
suggest
splenic
mz
lr
may
provid
optim
microenvironment
platform
reciproc
interact
among
thu
preform
trimolecular
complex
rapidli
activ
classic
complement
pathway
spleen
directli
recogn
pneumonia
preform
trimolecular
complex
splenic
mz
lr
could
acceler
gener
classic
pathway
convertas
result
abund
could
sequenti
promot
fixat
cell
surfac
support
possibl
particularli
enrich
splenic
lr
despit
lowest
express
spleen
among
examin
mous
tissu
therefor
splenic
mz
lr
may
optim
activ
although
distribut
independ
exist
probabl
due
coval
fixat
fragment
splenic
cell
complement
system
tightli
control
physiolog
condit
prevent
signific
damag
selftissu
enrich
splenic
mz
lr
could
also
precis
regul
complement
activ
splenic
mz
inde
nascent
regul
activ
concert
normal
condit
pneumococc
challeng
increas
activ
splenic
mz
lr
without
involv
complement
pathway
therefor
splenic
mz
lr
may
provid
optim
locat
activ
acceler
pneumococc
clearanc
sequenti
enhanc
pneumococc
opson
rapid
phagocytosi
primarili
splenic
mz
macrophag
particular
pneumonia
capsul
inhibit
recognit
natur
igm
bind
serum
protein
subcapsular
target
complement
activ
neutrophil
phagocytosi
howev
enrich
splenic
mz
lr
could
dramat
enhanc
simultan
recognit
pneumococc
cpss
thu
overcom
impair
initi
pneumococc
recognit
human
spleen
classic
pathway
integr
protect
infect
pneumonia
see
figur
previou
page
fig
dcsign
splenic
lipid
raft
may
mediat
classic
complement
pathway
respons
pneumonia
challeng
interact
dcekdcsign
transfect
incub
mitomycin
ctreat
pneumonia
type
min
immunostain
dcsign
without
permeabil
repres
cell
shown
box
b
dcekdcsign
transfect
incub
h
lysat
fraction
sucros
gradient
ultracentrifug
fraction
lr
immunoblot
dcsign
c
dcsign
bmt
tko
mice
inject
intraven
cfselabel
green
min
h
splenic
section
immunostain
dcsign
red
b
spleen
dcsign
bmt
tko
mice
use
intraven
inject
live
pneumonia
h
e
left
wildtyp
dcek
transfect
incub
endotoxinfre
ovalbumin
efova
human
sera
nm
nh
human
serum
tc
buffer
h
lysat
immunoblot
right
wildtyp
dcekdcsign
transfect
incub
nm
h
immunostain
follow
microscop
analysi
repres
area
highlight
lowpow
imag
figur
f
wildtyp
dcek
transfect
incub
nm
min
immunostain
without
permeabil
analyz
fac
g
empti
vector
dcsigntransfect
cell
incub
without
absenc
presenc
nh
min
cell
lysat
immunoblot
dcsign
h
dcsign
bmt
tko
mice
use
splenic
fraction
immunoblot
control
tko
dcsign
bmt
tko
mice
inject
intraven
sera
collect
min
immunoblot
j
c
control
ko
tko
dcsign
bmt
tko
mice
intraven
inject
min
splenic
section
immunostain
red
green
red
dcsign
green
repres
area
highlight
lowpow
imag
figur
k
h
spleen
cadav
use
immunoblot
repres
data
present
result
four
cadav
scale
bar
e
c
j
particular
complex
could
also
mediat
classic
complement
pathway
pneumonia
spleen
repres
potenti
protect
mechan
human
spleen
inde
replac
dcsign
splenic
mz
dcsign
bmt
tko
mice
complet
rescu
pneumococc
captur
sequenti
activ
deposit
pneumonia
splenic
mz
like
relat
dcsigninduc
complex
mous
previou
studi
shown
recruit
dcsign
lr
bind
viral
glycoprotein
strengthen
possibl
format
tetramolecular
complex
glycoprotein
thu
increas
bind
capac
complex
therefor
similar
splenic
mz
dcsign
lr
may
also
provid
favor
microenviron
dcsignmedi
classic
complement
pathway
form
anoth
tetramolecular
complex
dcsign
final
enhanc
sequenti
activ
dcsign
exclus
express
human
splenic
perifollicular
zone
macrophag
presenc
dcsign
cadav
splenic
lr
indic
dcsign
express
lr
human
splenic
perifollicular
zone
macrophag
also
similar
previou
report
complement
enrich
human
splenic
lr
therefor
cadav
splenic
perifollicular
zone
dcsign
lr
may
also
import
dcsignmedi
classic
complement
system
pneumonia
explain
spleen
classic
pathway
integr
protect
infect
pneumonia
human
import
lr
restrict
role
receptormedi
intracellular
event
plasma
membran
far
howev
splenic
mz
lr
provid
bidirect
platform
usual
event
associ
intracellular
milieu
exampl
recognit
phagocytosi
pathogen
vivo
also
unusu
event
associ
extracellular
milieu
complement
system
orchestr
earli
complic
host
respons
microbi
infect
thu
spleen
could
equip
sensit
system
target
variou
pathogen
pneumonia
human
immunodefici
find
explain
small
portion
splenic
macrophag
help
spleen
effici
protect
host
pneumonia
provid
insight
involv
lr
innat
immun
system
role
dcsign
human
spleen
streptococcu
pneumonia
capsular
serotyp
unencapsul
pneumonia
mutant
staphylococcu
aureu
strain
use
kindli
provid
professor
vincent
fischetti
rockefel
univers
new
york
usa
cell
cultur
dcek
mous
lcell
fibroblast
line
human
embryon
kidney
cell
cultur
medium
cho
cell
cultur
dulbecco
modifi
eagl
medium
supplement
fetal
bovin
serum
uml
penicillin
g
mgml
streptomycin
stabl
dcek
transfect
express
complementari
cdna
dcsign
dcekdcsign
figur
respect
stabl
cho
transfect
express
cdna
neo
choneo
figur
respect
use
femal
mice
week
old
weigh
g
purchas
jackson
laboratori
bar
harbor
usa
hous
specif
pathogenfre
condit
ko
mice
kindli
provid
consortium
function
glycom
http
wwwfunctionalglycomicsorg
dcsign
transgen
donor
mice
provid
rockefel
gene
target
resourc
center
identifi
pcr
use
dcsign
gene
primer
forward
revers
vivo
experi
use
anim
model
studi
approv
institut
anim
care
use
committe
konkuk
univers
permit
number
perform
strict
accord
approv
guidelin
anim
care
anim
experiment
anim
welfar
overseen
local
committe
mice
hous
temperaturecontrol
room
autom
darknesslight
cycl
system
ad
libitum
access
food
water
mice
challeng
colonyform
unit
pneumonia
suspend
ml
pb
pb
intraven
prior
tissu
dissect
mice
sacrif
via
euthanasia
use
overdos
co
flow
rate
cage
volum
per
minut
follow
avma
guidelin
euthanasia
anim
streptococcu
pneumonia
capsular
serotyp
unencapsul
pneumonia
mutant
staphylococcu
aureu
grown
brain
heart
infus
broth
difco
midlogarithm
phase
h
bacteria
inactiv
mitomycin
c
sigma
h
suspens
bacteria
label
follow
manufactur
instruct
mm
cfse
sigmaaldrich
min
fluoresc
bacteria
inject
intraven
mice
incub
cell
cell
coverslip
oct
tissuetek
frozen
spleen
section
fix
aceton
min
room
temperatur
stain
indic
dapi
blue
fitc
pe
amca
alexa
fluorconjug
donkey
antichicken
igi
goat
antihamst
igg
donkey
antirabbit
igg
goat
antirat
igg
streptavidin
secondari
reagent
purchas
abcam
jackson
immunoresearch
laboratori
molecular
probe
cell
spleen
section
examin
fluoresc
deconvolut
fluoresc
microscop
olympu
corp
tokyo
japan
imag
acquir
coolsnap
ez
system
roper
scientif
inc
az
usa
cell
use
fac
analysi
detach
mm
edta
pb
min
preincub
min
monoclon
antibodi
block
fc
receptor
cell
pneumonia
incub
mous
human
serum
tc
buffer
mm
trishcl
mm
nacl
mm
cacl
mm
mgcl
bovin
serum
albumin
bsa
complement
bind
cell
organ
detect
immunostain
respect
antibodi
min
cytometr
analysi
perform
use
facscan
becton
dickinson
san
jose
ca
usa
cellquestpro
bd
bioscienc
subsequ
data
analysi
perform
cellquestpro
bd
bioscienc
cell
incub
mitomycin
ctreat
cfselabel
pneumonia
indic
time
bacteri
bind
cell
cytoplasm
decomposit
capsular
polysaccharid
pneumonia
examin
fluoresc
microscop
mice
intraven
inject
mitomycin
ctreat
cfselabel
pneumonia
indic
time
bacteri
bind
decomposit
examin
cell
spleen
tissu
quantifi
pneumococc
decomposit
ratio
number
pneumococcalbound
decompos
cell
count
averag
percentag
pneumococcaldecompos
cell
total
number
pneumococcalbound
cell
calcul
five
area
sampl
five
independ
experi
tissu
mice
cell
solubil
ml
triton
junsei
chemic
co
ltd
mesbuff
salin
mb
mm
me
ph
mm
nacl
homogen
upanddown
stroke
tightfit
dounc
homogen
tissu
cellular
extract
adjust
ml
sucros
concentr
respect
overlaid
ml
sucros
ml
sucros
mb
sucros
gradient
form
centrifug
g
h
use
beckman
rotor
centrifug
sucros
gradient
fraction
fraction
without
pellet
opaqu
buoyant
band
correspond
lr
collect
interfac
sucros
gradient
quantiti
protein
fraction
use
immunoblot
analysi
clone
pmx
dcsign
gift
dr
chae
gyu
park
rockefel
univers
clone
c
dcsign
express
monitor
immunoblot
analysi
use
antidcsign
antibodi
dcek
transfect
transient
transfect
plasmid
encod
dynamin
ii
dominantneg
dynamin
point
mutat
nucleotidebind
site
gift
professor
seungja
lee
seoul
nation
univers
colleg
medicin
seoul
korea
empti
vector
h
use
lipofectamin
plu
reagent
invitrogen
life
technolog
carlsbad
ca
usa
accord
manufactur
specif
tko
isotyp
control
mice
gener
intraven
inject
antibodi
isotyp
hamster
igg
h
antibodi
select
transient
deplet
surfac
molecul
macrophag
splenic
mz
permit
analysi
function
vivo
previou
report
control
mice
obtain
intraperiton
inject
ukg
cobra
venom
factor
one
day
prior
experiment
challeng
deplet
confirm
western
blot
analysi
use
sera
mitomycin
ctreat
fluoresc
bacteria
intraven
administ
mice
indic
time
mice
sacrif
spleen
section
examin
deconvolut
fluoresc
microscopi
quantifi
process
tissu
vivo
pneumonia
inject
intraven
tissu
lysat
collect
indic
time
separ
sodium
dodecyl
sulfat
polyacrylamid
gel
electrophoresi
sdspage
immunoblot
polyclon
antimous
antibodi
vitro
process
pneumonia
incub
nh
tc
buffer
mm
nacl
mm
cacl
mm
mgcl
mm
tri
ph
supplement
bsa
min
bacteria
wash
mix
boil
sd
sampl
buffer
bacteri
lysat
separ
sdspage
immunoblot
polyclon
antimous
antibodi
antibodi
detect
compon
nativ
well
fragment
molecular
weight
human
kda
kda
kda
kda
fragment
kda
molecular
weight
rat
kda
kda
kda
fragment
kda
gener
process
convertas
immunoblot
analysi
steadi
state
predomin
larger
activ
larger
rapidli
process
smaller
fragment
includ
kda
serv
load
control
immunoblot
analysi
result
loss
detect
well
larger
accumul
smaller
activ
immunoblot
analysi
tissu
cell
bacteria
lyse
ripa
buffer
mm
nacl
mm
trishcl
ph
nonidet
sodium
sd
supplement
proteas
inhibitor
cocktail
sigma
lyse
sampl
mix
equal
volum
sd
sampl
buffer
contain
boil
min
min
dilut
sera
fraction
lr
mix
sd
sampl
buffer
boil
min
min
sampl
separ
sdspage
gradient
gel
transfer
polyvinyliden
difluorid
membran
follow
incub
antibodi
antibodyreact
band
blot
visual
peroxidaselabel
secondari
antibodi
follow
treatment
westzol
plu
intron
immobilon
millipor
human
cadaver
spleen
donat
depart
anatomi
school
medicin
konkuk
univers
seoul
korea
fluoresc
imag
analyz
metamorph
softwar
univers
imag
immunoblot
signal
detect
use
fuji
film
number
cell
bind
bacteria
number
cell
decompos
bacteria
count
averag
percentag
pneumococc
decomposit
total
pneumococc
bind
cell
calcul
five
area
sampl
three
independ
experi
shown
indic
graph
data
present
mean
sd
statist
signific
group
determin
twoway
analysi
varianc
follow
tukey
post
hoc
test
unpair
student
test
twotail
test
p
valu
taken
indic
statist
signific
signific
ns
p
p
p
publish
note
springer
natur
remain
neutral
regard
jurisdict
claim
publish
map
institut
affili
